IHH Healthcare

IHH

MYL5225OO007

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
6.25 ^MYR	+0.81%		+2.63%	+3.65%

Apr. 05	IHH Healthcare Names CFO	MT
Apr. 05	IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer	CI

IHH Healthcare Berhad Reports Impairment for the Fourth Quarter Ended December 31, 2021

February 23, 2022 at 05:20 am EST

IHH Healthcare Berhad reported impairment for the fourth quarter ended December 31, 2021. For the quarter, the company reported impairment loss on goodwill was MYR 6,090,000.

Latest news about IHH Healthcare

IHH Healthcare Names CFO	Apr. 05	MT
IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer	Apr. 05	CI
Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024	Mar. 29	CI
Ihh Healthcare Berhad Appoints Yoichiro Endo as Non Independent and Non Executive Director	Mar. 29	CI
Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee	Mar. 29	CI
Ihh Healthcare Berhad Appoints Yoichiro Endo as Non Independent and Non Executive Member of Nomination and Remuneration Committee	Mar. 29	CI
IHH Healthcare Seeks Shareholder Approval for Buyback Program	Mar. 28	MT
IHH Healthcare Issues New Shares Pursuant to Exercise of Options	Mar. 24	MT
Transcript : IHH Healthcare Berhad, Q4 2023 Earnings Call, Mar 01, 2024	Feb. 29
Ihh Healthcare Berhad Announces Final Single Tier Cash Dividend for the Financial Year Ended 31 December 2023, Payable on 26 April 2024	Feb. 29	CI
IHH Healthcare Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
IHH Healthcare Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
IHH Healthcare Withdraws IPO Plans for Indian Lab	Feb. 14	DJ
IHH Healthcare Indirect Unit's Subsidiary Scraps Proposed India IPO	Feb. 14	MT
IHH Healthcare's MYR245 Million Acquisition of Bedrock Healthcare Becomes Unconditional	Feb. 04	MT
IHH Healthcare's CFO Steps Down	Feb. 01	MT
IHH Healthcare Berhad Announces Cessation of Joerg Ayrle as Chief Financial Officer	Jan. 31	CI
India's big hospital chains think small to expand in booming market	Dec. 21	RE
IHH Healthcare seeks acquisitions in Indonesia, Vietnam; eyes turnaround in China	Dec. 01	RE
IHH Healthcare's Attributable Profit More Than Doubles in Q3	Nov. 30	MT
Transcript : IHH Healthcare Berhad, Q3 2023 Earnings Call, Dec 01, 2023	Nov. 30
IHH Healthcare Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 30	CI
IHH Healthcare Associate Divesting Indian Hospital for INR1.3 Billion	Nov. 26	MT
IHH Healthcare Gets Shareholders' Nod to Commence Voluntary Liquidation of Unit	Nov. 21	MT
IHH Healthcare Unit Pursues Legal Action Against Daiichi Sankyo Over Fortis Deal	Nov. 14	MT

IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company's segments include Hospital and Healthcare, IMU Health, Labs, PLife REIT and Others. It operates its Hospital and Healthcare segment in Singapore, Malaysia, India, Greater China, Turkey and Europe and Southeast Asia. The IMU Health segment is engaged in providing educational services. The Labs segment provides diagnostic laboratory services. The PLife REIT segment is a real estate investment trust. Through its portfolio of brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway, the Company offers its patients comprehensive and personalized care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging, and rehabilitation. It provides day-to-day healthcare services through outpatient treatment, routine check-ups, and vaccinations. Its secondary care comprises specialist consultation, local surgeries, and others.

Sector

Healthcare Facilities & Services

Calendar

2024-05-28 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for IHH Healthcare

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.25 MYR

Average target price

7.13 MYR

Spread / Average Target

+14.09%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
IHH HEALTHCARE	+3.65%	11.43B
AIER EYE HOSPITAL GROUP CO., LTD.	-22.63%	15.4B
BANGKOK DUSIT MEDICAL SERVICES	+3.60%	12.12B
APOLLO HOSPITALS ENTERPRISE LIMITED	+11.92%	10.84B
ENCOMPASS HEALTH CORPORATION	+24.00%	8.29B
RAMSAY HEALTH CARE LIMITED	-2.19%	7.78B
MOUWASAT MEDICAL SERVICES COMPANY	+20.75%	7.33B
THE ENSIGN GROUP, INC.	+4.53%	6.75B
GLOBAL HEALTH LIMITED	+49.97%	4.65B
DALLAH HEALTHCARE COMPANY	-5.01%	4.31B

Hospitals, Clinics & Primary Care Services

IHH Healthcare

Equities

IHH

MYL5225OO007

Healthcare Facilities & Services

IHH Healthcare Berhad Reports Impairment for the Fourth Quarter Ended December 31, 2021

Latest news about IHH Healthcare

Chart IHH Healthcare

Company Profile

Income Statement Evolution

Ratings for IHH Healthcare

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Hospitals, Clinics & Primary Care Services